ProKidney’s stock rockets on ‘intriguing’ news, but analyst doesn’t recommend buying

3 months ago 13

ARTICLE AD BOX

ProKidney’s stock was the biggest gainer and most actively traded on Tuesday following “very intriguing” news regarding the biotech’s CKD and diabetes treatment.

Read Entire Article

ProKidney’s stock rockets on ‘intriguing’ news, but analyst doesn’t recommend buying

ARTICLE AD BOX

Related

A dividend-paying ‘vending machine’ — this oil stock weather...

If New York or California enter a recession, the entire U.S....

How can Anthropic stand out in the AI wars? I went to a Gree...

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Netflix scuttles plans to add six previously announced games...

OpenAI co-founder John Schulman has left Anthropic after les...

Steam will label early access games that haven't been update...

‘I didn’t want to spend time with my children. I was just go...